CIARDIELLO, Fortunato
CIARDIELLO, Fortunato
Dipartimento di Medicina di Precisione
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
2011 Stahel, R; Thatcher, N; Früh, M; Le Péchoux, C; Postmus, Pe; Sorensen, Jb; Felip, E; Gandara, D; Reck, M; Baas, P; Roussy, G; Blackhall, F; Cappuzzo, F; Ciardiello, Fortunato; Magrassi, F; Lanzara, A; Crinò, L; de Marinis, F; Dziadziuszko, R; Eberhardt, W; Faivre Finn, C; Felip, E; Früh, M; Gandara, D; Gridelli, C; Goss, G; Jänne, Pa; Kerr, K; Lee, Sm; Le Péchoux, C; Manegold, C; Mcgregor, K; Mok, T; O'Byrne, K; Paz Ares, L; Pirker, R; Postmus, Pe; Reck, M; Rosell, R; Senan, S; Smit, Ef; Sorensen, Jb; Stahel, Ra; Taron, M; Thatcher, N; van Meerbeeck, Jp; Van Schil, P; Vansteenkiste, J; Vergnenegre, A; Weder, W.
30 Immunotherapy in advanced NSCLC-from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)
2018 de Marinis, Filippo; Ciardiello, Fortunato; Baas, Paul; Crinò, Lucio; Giaccone, Giuseppe; Grossi, Francesco; Hellmann, Matthew D; Mok, Tony S K; Lena, Hervè; Paz-Ares, Luis; Rodriguez-Abreu, Delvys; Von Pavel, Joachim; Gridelli, Cesare
8-chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in humancolon cancer cells
1996 Diisernia, G; Ciardiello, Fortunato; Sandomenico, C; Pepe, S; Bianco, A; Tortora, G.
8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo
2000 Indolfi, C; DI LORENZO, E; Rapacciuolo, A; Stingone, Am; Stabile, E; Leccia, A; Torella, D; Caputo, R; Ciardiello, Fortunato; Tortora, G; Chiariello, M.
8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation
1990 Ciardiello, Fortunato; Tortora, G; Kim, N; Clair, T; Ally, S; Salomon, Ds; CHO CHUNG, Ys
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer
1997 Bianco, C; Tortora, G; Baldassarre, G; Caputo, R; Fontanini, G; Chine, S; Bianco, Ar; Ciardiello, Fortunato
[Rationales for the integration of molecular and conventional therapies]
2002 Tortora, G; Ciardiello, Fortunato
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant
2019 De Falco, V.; Natalicchio, M. I.; Napolitano, S.; Coppola, N.; Conzo, G.; Martinelli, E.; Zanaletti, N.; Vitale, P.; Giunta, E. F.; Vietri, M. T.; Vitiello, P. P.; Ciardiello, D.; Marinaccio, A.; De Vita, F.; Ciardiello, F.; Troiani, T.
A meta-analysis on the interactionbetween HER-2 expression and response to endocrine treatment in advanced breastcancer
2005 De Laurentiis, M; Arpino, G; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, Fortunato; Tortora, G; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; De Placido, S.
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer
2011 DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Vecchione, L; Innocenti, R; Sileni, Vc; Pinto, C; Di Maio, M; Farella, A; Troiani, Teresa; Morgillo, Floriana; Napolitano, Vincenzo; Ancona, E; Di Martino, N; Ruol, A; Galizia, Gennaro; Del Genio, A; Ciardiello, Fortunato
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial.
2015 Fasano, M; DELLA CORTE, Carminia Maria; Capuano, Annalisa; Sasso, Ferdinando Carlo; Papaccio, F; Berrino, Liberato; Ciardiello, Fortunato; Morgillo, Floriana
A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine
In corso di stampa Dotolo, Serena; Marabotti, Anna; Rachiglio, Anna Maria; Esposito Abate, Riziero; Benedetto, Marco; Ciardiello, Fortunato; De Luca, Antonella; Normanno, Nicola; Facchiano, Angelo; Tagliaferri, Roberto
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor
2001 Ciardiello, Fortunato; Tortora, G.
A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
2023 Landi, N.; Ciaramella, V.; Ragucci, S.; Chambery, A.; Ciardiello, F.; Pedone, P. V.; Troiani, T.; Di Maro, A.
A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer
2000 Tortora, G; Caputo, R; Damiano, V; Bianco, R; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, Fortunato
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
2005 DE VITA, Ferdinando; Orditura, Michele; Matano, E.; Bianco, R.; Carlomagno, C.; Infusino, S.; Damiano, V.; Simeone, E.; Diadema, M. R.; Lieto, Eva; Castellano, P.; Pepe, S.; DE PLACIDO, S.; Galizia, Gennaro; DI MARTINO, Natale; Ciardiello, Fortunato; Catalano, G.; Bianco, A.
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC).
2010 Aurilio, G; Ricci, V; DE VITA, Ferdinando; Fasano, M; Fazio, N; Orditura, Michele; Funicelli, L; DE LUCA, G; Iasevoli, D; Iovino, Francesco; Ciardiello, Fortunato; Conzo, Giovanni; Nole', F; Lamendola, M.
A preliminary study for quantitative assessment with HFUS (High-frequency ultrasound) of nodular skin melanoma breslow thickness in adults before surgery: Interdisciplinary team experience
2020 Reginelli, A.; Belfiore, M. P.; Russo, A.; Turriziani, F.; Moscarella, E.; Troiani, T.; Brancaccio, G.; Ronchi, A.; Giunta, E.; Sica, A.; Iovino, F.; Ciardiello, F.; Franco, R.; Argenziano, G.; Grassi, R.; Cappabianca, S.
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
2022 Argilés, Guillem; Mulet, Nuria; Valladares-Ayerbes, Manuel; Viéitez, José M; Grávalos, Cristina; García-Alfonso, Pilar; Santos, Cristina; Tobeña, María; García-Paredes, Beatriz; Benavides, Manuel; Cano, María T; Loupakis, Fotios; Rodríguez-Garrote, Mercedes; Rivera, Fernando; Goldberg, Richard M; Cremolini, Chiara; Bennouna, Jaafar; Ciardiello, Fortunato; Tabernero, Josep M; Aranda, Enrique; Argilés, Guillem; Tabernero, Josep
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamics
2007 Gridelli, C; Rossi, A; Morgillo, Floriana; Bareschino, Ma; Maione, P; DI MAIO, M; Ciardiello, Fortunato
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. | 1-gen-2011 | Stahel, R; Thatcher, N; Früh, M; Le Péchoux, C; Postmus, Pe; Sorensen, Jb; Felip, E; Gandara, D; Reck, M; Baas, P; Roussy, G; Blackhall, F; Cappuzzo, F; Ciardiello, Fortunato; Magrassi, F; Lanzara, A; Crinò, L; de Marinis, F; Dziadziuszko, R; Eberhardt, W; Faivre Finn, C; Felip, E; Früh, M; Gandara, D; Gridelli, C; Goss, G; Jänne, Pa; Kerr, K; Lee, Sm; Le Péchoux, C; Manegold, C; Mcgregor, K; Mok, T; O'Byrne, K; Paz Ares, L; Pirker, R; Postmus, Pe; Reck, M; Rosell, R; Senan, S; Smit, Ef; Sorensen, Jb; Stahel, Ra; Taron, M; Thatcher, N; van Meerbeeck, Jp; Van Schil, P; Vansteenkiste, J; Vergnenegre, A; Weder, W. | |
| 30 Immunotherapy in advanced NSCLC-from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT) | 1-gen-2018 | de Marinis, Filippo; Ciardiello, Fortunato; Baas, Paul; Crinò, Lucio; Giaccone, Giuseppe; Grossi, Francesco; Hellmann, Matthew D; Mok, Tony S K; Lena, Hervè; Paz-Ares, Luis; Rodriguez-Abreu, Delvys; Von Pavel, Joachim; Gridelli, Cesare | |
| 8-chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in humancolon cancer cells | 1-gen-1996 | Diisernia, G; Ciardiello, Fortunato; Sandomenico, C; Pepe, S; Bianco, A; Tortora, G. | |
| 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo | 1-gen-2000 | Indolfi, C; DI LORENZO, E; Rapacciuolo, A; Stingone, Am; Stabile, E; Leccia, A; Torella, D; Caputo, R; Ciardiello, Fortunato; Tortora, G; Chiariello, M. | |
| 8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation | 1-gen-1990 | Ciardiello, Fortunato; Tortora, G; Kim, N; Clair, T; Ally, S; Salomon, Ds; CHO CHUNG, Ys | |
| 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer | 1-gen-1997 | Bianco, C; Tortora, G; Baldassarre, G; Caputo, R; Fontanini, G; Chine, S; Bianco, Ar; Ciardiello, Fortunato | |
| [Rationales for the integration of molecular and conventional therapies] | 1-gen-2002 | Tortora, G; Ciardiello, Fortunato | |
| A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant | 1-gen-2019 | De Falco, V.; Natalicchio, M. I.; Napolitano, S.; Coppola, N.; Conzo, G.; Martinelli, E.; Zanaletti, N.; Vitale, P.; Giunta, E. F.; Vietri, M. T.; Vitiello, P. P.; Ciardiello, D.; Marinaccio, A.; De Vita, F.; Ciardiello, F.; Troiani, T. | |
| A meta-analysis on the interactionbetween HER-2 expression and response to endocrine treatment in advanced breastcancer | 1-gen-2005 | De Laurentiis, M; Arpino, G; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, Fortunato; Tortora, G; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; De Placido, S. | |
| A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer | 1-gen-2011 | DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Vecchione, L; Innocenti, R; Sileni, Vc; Pinto, C; Di Maio, M; Farella, A; Troiani, Teresa; Morgillo, Floriana; Napolitano, Vincenzo; Ancona, E; Di Martino, N; Ruol, A; Galizia, Gennaro; Del Genio, A; Ciardiello, Fortunato | |
| A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. | 1-gen-2015 | Fasano, M; DELLA CORTE, Carminia Maria; Capuano, Annalisa; Sasso, Ferdinando Carlo; Papaccio, F; Berrino, Liberato; Ciardiello, Fortunato; Morgillo, Floriana | |
| A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine | In corso di stampa | Dotolo, Serena; Marabotti, Anna; Rachiglio, Anna Maria; Esposito Abate, Riziero; Benedetto, Marco; Ciardiello, Fortunato; De Luca, Antonella; Normanno, Nicola; Facchiano, Angelo; Tagliaferri, Roberto | |
| A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor | 1-gen-2001 | Ciardiello, Fortunato; Tortora, G. | |
| A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells | 1-gen-2023 | Landi, N.; Ciaramella, V.; Ragucci, S.; Chambery, A.; Ciardiello, F.; Pedone, P. V.; Troiani, T.; Di Maro, A. | |
| A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer | 1-gen-2000 | Tortora, G; Caputo, R; Damiano, V; Bianco, R; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, Fortunato | |
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients | 1-gen-2005 | DE VITA, Ferdinando; Orditura, Michele; Matano, E.; Bianco, R.; Carlomagno, C.; Infusino, S.; Damiano, V.; Simeone, E.; Diadema, M. R.; Lieto, Eva; Castellano, P.; Pepe, S.; DE PLACIDO, S.; Galizia, Gennaro; DI MARTINO, Natale; Ciardiello, Fortunato; Catalano, G.; Bianco, A. | |
| A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). | 1-gen-2010 | Aurilio, G; Ricci, V; DE VITA, Ferdinando; Fasano, M; Fazio, N; Orditura, Michele; Funicelli, L; DE LUCA, G; Iasevoli, D; Iovino, Francesco; Ciardiello, Fortunato; Conzo, Giovanni; Nole', F; Lamendola, M. | |
| A preliminary study for quantitative assessment with HFUS (High-frequency ultrasound) of nodular skin melanoma breslow thickness in adults before surgery: Interdisciplinary team experience | 1-gen-2020 | Reginelli, A.; Belfiore, M. P.; Russo, A.; Turriziani, F.; Moscarella, E.; Troiani, T.; Brancaccio, G.; Ronchi, A.; Giunta, E.; Sica, A.; Iovino, F.; Ciardiello, F.; Franco, R.; Argenziano, G.; Grassi, R.; Cappabianca, S. | |
| A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial) | 1-gen-2022 | Argilés, Guillem; Mulet, Nuria; Valladares-Ayerbes, Manuel; Viéitez, José M; Grávalos, Cristina; García-Alfonso, Pilar; Santos, Cristina; Tobeña, María; García-Paredes, Beatriz; Benavides, Manuel; Cano, María T; Loupakis, Fotios; Rodríguez-Garrote, Mercedes; Rivera, Fernando; Goldberg, Richard M; Cremolini, Chiara; Bennouna, Jaafar; Ciardiello, Fortunato; Tabernero, Josep M; Aranda, Enrique; Argilés, Guillem; Tabernero, Josep | |
| A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamics | 1-gen-2007 | Gridelli, C; Rossi, A; Morgillo, Floriana; Bareschino, Ma; Maione, P; DI MAIO, M; Ciardiello, Fortunato |